About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Not Yet Recruiting

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

NCT06623084•Stefania Basili

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Non-alcoholic Fatty Liver Disease (NAFLD)NASH - Nonalcoholic SteatohepatitisCirrhosis+1 more

Interventions

Platelets characterization

Key Dates

Start Date

September 30, 2024

Primary Completion Date

March 12, 2025

Completion Date

December 24, 2025

Last Updated

October 4, 2024

Related Studies

Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement

NCT07439939

Liver CirrhosisPortal Hypertension

Online Prehabilitation for Patients Awaiting Liver Transplantation

NCT05899231

Cirrhosis, LiverLiver Transplant Surgery+1 more

EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endoscopic Variceal Ligation in Patients With Chronic Hepatitis.

NCT05597488

Cirrhosis Portal

Utilizing of Physiological Parameters Predict the Prognosis of Cirrhotic Patients With Gastrointestinal Bleeding

NCT06680583

Liver CirrhosisGastrointestinal Bleeding

Copper Supplementation in Cirrhosis

NCT07471542

CirrhosisChronic Liver Disease+2 more

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

NCT07469319

Hepatocellular Carcinoma (HCC)Cirrhosis

View all related studies

Contacts

Stefania Basili, MD

CONTACT

+390649972018 stefania.basili@uniroma1.it

Sponsors

Lead Sponsor

Stefania Basili

Collaborators

University of Rome Tor Vergata
Catholic University of the Sacred Heart

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 4, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions